First-in-Human trial tests Anti-Aging gene shot
NCT ID NCT07285629
Summary
This is an early safety study testing a new gene therapy injection in healthy adults aged 50-80. The therapy aims to deliver two genes, klotho and follistatin, which may improve physical function, thinking skills, and overall health. Researchers will monitor participants closely for safety and measure changes in their health, fitness, and cognition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Apeiron Center
RECRUITINGAustin, Texas, 78701, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Global Alliance of Regenerative Medicine (GARM) Clinic
NOT_YET_RECRUITINGRoatán, Bay Islands, Honduras
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.